hat
Pou itilizasyon alfa-GPC nan sentòm atenuasyon nan bès mantal, prèske tout etid yo itilize yon dòz 1,200 mg chak jou, divize an twa dòz 400 mg. Li se sèten ki jan pi ba dòz ta benefisye koyisyon, men mg nan 1,200 parèt yo dwe toujou asosye ak benefis yo.
eng
For the usage of alpha-GPC in attenuating symptoms of cognitive decline, almost all studies use a dosage of 1,200 mg daily, divided into three doses of 400 mg. It is unsure how lower doses would benefit cognition, but the 1,200 mg appears to be consistently associated with benefit.